STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRL
  4. [144] CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing

Charles River (NYSE: CRL) director plans new sale after $24.8M stock sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is the issuer for a planned resale of its common stock under Rule 144 by director James Foster. The notice covers 33,561 shares of common stock, with an aggregate market value of $10,065,950.73, relative to 47,738,872 shares outstanding as of August 25, 2026.

The shares are to be sold through UBS Financial Services, Inc. on the NYSE, in connection with an exercise of stock options for cash on August 25, 2026. Foster also reported prior sales in the past three months totaling 103,733 shares for combined proceeds of $24,776,575.00.

Positive

  • None.

Negative

  • None.
Shares to be sold 33,561 shares Common stock covered by the Rule 144 notice for August 25, 2026
Aggregate market value of shares to be sold $10,065,950.73 Market value of 33,561 CRL common shares listed in the notice
Shares outstanding 47,738,872 shares CRL common shares outstanding as of August 25, 2026
Shares sold June 29, 2026 75,000 shares Common shares sold by James Foster on June 29, 2026
Proceeds June 29, 2026 sale $16,875,000.00 Value of 75,000 CRL shares sold on June 29, 2026
Shares sold August 10, 2026 28,733 shares Common shares sold by James Foster on August 10, 2026
Proceeds August 10, 2026 sale $7,901,575.00 Value of 28,733 CRL shares sold on August 10, 2026
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
attorney-in-fact regulatory
"Signature | /s/ UBS Financial Services Inc, as attorney-in-fact for James Foster"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Exercise of stock options financial
"Common | 08/25/2026 | Exercise of stock options | Issuer"

FAQ

What does the Form 144 filed for CRL disclose about planned stock sales?
The notice states that director James Foster plans to sell 33,561 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. common stock under Rule 144, with an aggregate market value of $10,065,950.73, based on market prices as of August 25, 2026.

How many CRL shares has James Foster sold in the past three months?
James Foster reported selling a total of 103,733 CRL shares in the past three months: 75,000 shares for $16,875,000.00 on June 29, 2026, and 28,733 shares for $7,901,575.00 on August 10, 2026.

What is the size of the planned CRL sale relative to shares outstanding?
The planned sale covers 33,561 shares of CRL common stock. The document lists 47,738,872 shares outstanding as of August 25, 2026, providing a reference point for the relative size of the proposed Rule 144 sale.

How will the CRL shares in this Form 144 be acquired before sale?
The shares covered by the notice are related to an exercise of stock options on August 25, 2026. The transaction is described as an option exercise for cash with the issuer as the counterparty, followed by potential resale under Rule 144.

Who is handling the planned CRL stock sale for James Foster?
The planned Rule 144 sale of 33,561 CRL shares will be handled by UBS Financial Services, Inc. at its Eleven Madison Avenue office, with the common stock listed for trading on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google